Charles Divita III - Sep 10, 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol: TDOC
Transactions as of: Sep 10, 2025
Transactions value $: -$127,435
Form type: 4
Date filed: 9/11/2025, 04:04 PM
Previous filing: Jun 11, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER, Director	C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, FLOOR 17, NEW YORK	/s/ Adam C. Vandervoort, Attorney-in-Fact	2025-09-11	0001347535

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+39.2K	+25%		196K	Sep 10, 2025	Direct	F1
transaction	TDOC	Common Stock	Sale	-$127K	-16.8K	-8.57%	$7.59	179K	Sep 11, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-39.2K	-12.5%	$0.00	274K	Sep 10, 2025	Common Stock	39.2K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.